In this interview we discuss the role of checkpoint inhibitors in advanced lung cancer and treatment strategies when patients progress.
Oncology Vol 31 No 6
In a Significant Percentage of Patients, Neoadjuvant Therapy Yields Equivalent Survival, With Better Quality of Life and Lower Costs
Cytoreductive Surgery Is the Best Way to Affect Survival Outcomes
Advertisement
Advertisement
Trending on CancerNetwork
1
Poorer Outcomes Observed for Black Patients Undergoing Chemotherapy for AML
2
Fixed-Duration Venetoclax Combos Show Noninferior PFS to Ibrutinib in CLL
3
Survival Benefit Seen With Cilta-Cel in Earlier Lines of Myeloma Treatment
4
Real-World Elranatamab Maintains Responses in Elderly, Frail R/R Multiple Myeloma
5
